Skip to main content
. 2018 Mar 9;13(3):e0194234. doi: 10.1371/journal.pone.0194234

Fig 1.

Fig 1

Freedom from locoregional failure (A), freedom from distant metastasis (B), freedom from colostomy (C), and overall survival (D) for all patients receiving IMRT with concurrent chemotherapy.